The Johns Hopkins Ependymoma and Subependymoma Center is part of the Comprehensive Brain Tumor Center, one of the largest brain tumor centers in the world. Our center is one of just a few in the country focused on these uncommon tumors.
Why Choose Johns Hopkins
Our ependymoma team includes doctors from a range of specialties, including neurology, neurosurgery, pediatrics, neuro-oncology and radiation oncology. This combined expertise ensures all aspects of your care are addressed
Ependymomas develop in delicate parts of the brain and spine, requiring careful, customized treatment plans. Our ependymoma experts tailor each patient's care to provide the safest, most effective approach.
Our research teams study all aspects of ependymoma — both in the lab and in the clinic — to develop new therapies that can improve the lives of those with these rare tumors.
Schedule an Appointment
In-person and telemedicine appointments are available for initial consultations and follow-up care.
For patients diagnosed with brain cancer who need a consultation with an oncologist:
Kimmel Cancer Center: 410-955-8964
Christie Adams, PA-C
Physician Assistant working with Chetan Bettegowda, M.D., Ph.D.
Jill Anderson, PA-C
Physician Assistant Manager working with Henry Brem, M.D.
Ashley Kang, PA-C
Physician Assistant working with Debraj Mukherjee, M.D., M.P.H.
Carla Scott, PA-C
Senior Physician Assistant working with Chris Jackson, M.D., and Judy Huang, M.D.
Ependymoma and Subependymoma Research
To deepen our understanding of ependymoma, our research team targets three areas: basic science, translational research and clinical practice:
Basic science: modeling ependymoma tumors and developing new treatment options
Translational research: bringing basic science findings to clinical trials
Clinical practice: optimizing current treatment protocols